Slides on Precision Management of Late Endocrine Effects in Cancer Survivors

Learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.
Wassim Chemaitilly, MD
Laurie E. Cohen, MD
Danielle N. Friedman, MD, MS
Steven G. Waguespack, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.61 MB
Released: March 18, 2021

Acknowledgements

Provided by the Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Downloadable slideset from Sagar Lonial, MD and Kathryn Maples, PharmD, BCOP on treatment options for patients with R/R myeloma, from Clinical Care Options (CCO).

Sagar Lonial, MD Kathryn Maples, PharmD, BCOP Released: May 4, 2021

Expert insight from Arjun Balar, MD, on choosing optimal therapy for patients with advanced urothelial cancer after chemo and IO, from Clinical Care Options (CCO)

person default Arjun Balar, MD person default Kaitlynn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 4, 2021 Expired: May 3, 2022

Slides from Arjun Balar, MD on the role of antibody-drug conjugates in early stage urothelial cancer, from Clinical Care Options (CCO)

person default Arjun Balar, MD Released: May 4, 2021

Jubilee Brown, MD, and Ursula Matulonis, MD, discuss current challenges in the management of endometrial and ovarian cancer, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: May 3, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue